ORBUS THERAPEUTICS
They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more positive outcome to patients facing life-threatening or significantly life-altering diseases. Currently, Orbus Therapeutics is working to develop and commercialize eflornithine in North America. The company was founded in 2012 and is headquartered in Palo Alto, California.
ORBUS THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.orbustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
650-656-9440
Total Funding:
55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Typekit Squarespace Squarespace Add To Cart Stocksy
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
BiPlastiq
BiPlastiq is a startup dedicated to developing radical technological advancements.
Carbylan Therapeutics
Carbylan Therapeutics was founded in 2004
i-Optics
i-Optics offers eye diagnosis solutions and products for age related eye diseases.
Odyssey Therapeutics
Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Current Advisors List
Current Employees Featured
Founder
Investors List
Agent Capital
Agent Capital investment in Series B - Orbus Therapeutics
Adams Street Partners
Adams Street Partners investment in Series A - Orbus Therapeutics
Ernest Mario
Ernest Mario investment in Series A - Orbus Therapeutics
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series A - Orbus Therapeutics
Longitude Capital
Longitude Capital investment in Series A - Orbus Therapeutics
Official Site Inspections
http://www.orbustherapeutics.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Orbus Therapeutics"
Leadership — Orbus Therapeutics
Jason Levin Founder, Chief Operating Officer. Prior to founding Orbus Therapeutics, Jason was Chief Business Officer of Sorbent Therapeutics, Inc., a company focused on the development …See details»
Orbus Therapeutics - Crunchbase Company Profile & Funding
They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more …See details»
Orbus Therapeutics - PitchBook
Www.orbustherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 2479 East Bayshore Road; Suite 105; Palo Alto, CA 94303; United States +1 (650) Primary …See details»
Orbus Therapeutics, Inc.: Contact Details and Business Profile
Orbus Therapeutics Inc. is a late-stage, private biopharmaceutical company that is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.See details»
Orbus Therapeutics, Inc. | Devex
Learn more about Orbus Therapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Orbus Therapeutics is dedicated to developing products that treat rare ...See details»
Orbus Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Orbus Therapeutics, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Orbus Therapeutics - Overview, News & Similar companies
Jan 18, 2022 Orbus Therapeutics contact info: Phone number: (650) 656-9440 Website: www.orbustherapeutics.com What does Orbus Therapeutics do? Orbus Therapeutics Inc. is a …See details»
Orbus Therapeutics Inc Management Team | Org Chart
Orbus Therapeutics Inc employs 27 employees. The Orbus Therapeutics Inc management team includes Jason Levin (Chief Operating Officer, Co-Founder, Board Member), Victor Levin …See details»
About Orbus - Orbus Therapeutics
Brain Cancer clinical trial for Anaplastic Astrocytoma. Since there is a need for better treatment options for patients diagnosed with AA, we are evaluating eflornithine in a clinical study. …See details»
Nextsource | Company Profile | Orbus Therapeutics
Explore the company profile of Orbus Therapeutics (orbustherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Our team helping patients with brain cancer. - Orbus Therapeutics
Oct 20, 2024 Since there is a need for better treatment options for patients diagnosed with AA, we are evaluating eflornithine in a clinical study. Patients with AA who have progressed or …See details»
Orbus Therapeutics - Craft
Orbus Therapeutics is a company dedicated to developing products that treat late-stage brain cancer and rare diseases. Its product candidate, eflornithine, is a cytostatic (growth-inhibiting) …See details»
Orbus Therapeutics CEO and Key Executive Team | Craft.co
Orbus Therapeutics's Founder, President and Chief Executive Officer, Director is Bob Myers. Other executives include Jason Levin, Founder, Chief Operating Officer, Director; Terry Gould, …See details»
Orbus Pharma Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Orbus Pharma Inc of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»
Orbus Therapeutics Announces First Patient Enrolled in
Sep 6, 2023 Investor Contact: Media Contact: Jason Levin, COO: Kelli Perkins: [email protected]: [email protected]: 650.656.9440: 310.625.3248See details»
Board Of Directors — Orbus Therapeutics
Oct 20, 2024 Ernest Mario, PhD | Chairman . In Memoriam (June 12, 1938 - October 20, 2024) Dr. Mario joined our board of directors as Chairman in August 2015.See details»
Partnering — Orbus Therapeutics
Orbus Therapeutics primary focus is development and commercialization of therapeutic products that treat patients suffering from rare diseases for which there are few available effective …See details»
orbus-news — Orbus Therapeutics
Nov 22, 2024 - The Phase 1 Study will Evaluate Eflornithine in Combination with Temozolomide - PALO ALTO, Calif., September 6, 2023 – Orbus Therapeutics Inc., a private, late-stage …See details»